Eko Foundation Analysis Software with Transformers (EFAST) vs Zio XT ECG Monitoring System

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

AI Verdict

EFAST is designed for real-time, point-of-care detection of structural murmurs and atrial fibrillation during routine physical exams using a digital stethoscope. In contrast, the Zio XT system provides continuous, long-term ambulatory ECG monitoring for up to 14 days via a wearable biosensor, primarily for detecting intermittent arrhythmias. Therefore, EFAST is suited for immediate diagnostic insights during an office visit, while Zio XT is for extended monitoring to capture less frequent cardiac events.

Choose Eko Foundation Analysis Software with Transformers (EFAST) if…

Choose EFAST if you need real-time, AI-powered insights during routine physical examinations to quickly screen for structural murmurs and atrial fibrillation. This tool is ideal for clinicians seeking immediate diagnostic support during auscultation, leveraging enhanced audio and waveform visualization for efficient cardiac assessments in a clinic setting.

View Eko Foundation Analysis Software with Transformers (EFAST) →

Choose Zio XT ECG Monitoring System if…

Choose Zio XT if you require extended, continuous cardiac monitoring to detect intermittent arrhythmias or capture symptomatic events over several days. This wearable biosensor is well-suited for patients needing comfortable, long-term ambulatory ECG recording for up to 14 days, providing comprehensive data for later analysis by AI and expert review.

View Zio XT ECG Monitoring System →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature Eko Foundation Analysis Software with Transformers (EFAST) Zio XT ECG Monitoring System
Pricing Subscription-based, contact for details Contact for pricing
Deployment Unknown Cloud-based (AWS EC2 platform), no on-premise hardware required.
BAA Available Yes AI-estimated Yes AI-estimated
FDA Status Cleared AI-estimated Yes AI-estimated
HIPAA Yes AI-estimated Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Eko Foundation Analysis Software with Transformers (EFAST)

EFAST offers real-time AI analysis and guided exams directly within the auscultation workflow, providing immediate, actionable insights for clinicians. This seamless integration into routine physical exams enhances efficiency and ease of use for healthcare providers.

Clinical Value

Eko Foundation Analysis Software with Transformers (EFAST)

EFAST provides high, published sensitivity and specificity rates for detecting structural murmurs (93% sensitivity, 91% specificity) and atrial fibrillation (95% sensitivity, 94% specificity) in real-time. This offers immediate, quantifiable clinical insights during routine exams, aiding in early diagnosis and intervention.

Pricing & Value

Zio XT ECG Monitoring System

Zio XT offers more transparent pricing examples with specific per-patient costs for its monitoring service in both the UK (u00a3310) and US (approx. $229-$260.35). This allows healthcare providers to more easily assess the direct cost and value per diagnostic event compared to EFAST's less detailed subscription and hardware pricing.

Enterprise Readiness

Tie

Both EFAST and Zio XT are cloud-based, FDA-cleared, HIPAA compliant, and offer Business Associate Agreements (BAAs), demonstrating robust regulatory and security readiness. Both also support EMR integration, which is crucial for seamless integration into existing healthcare workflows and enterprise adoption.

Innovation

Eko Foundation Analysis Software with Transformers (EFAST)

EFAST leverages advanced AI, specifically mentioning 'Transformers,' to provide real-time, actionable cardiac insights during routine auscultation, transforming a traditional physical exam into an AI-assisted diagnostic process. This application of cutting-edge AI at the point of care represents a significant innovation in immediate cardiac screening.

Support & Docs

Tie

The provided information and general web searches indicate that both Eko Health and iRhythm Technologies offer standard support resources and documentation for their respective products. Without more specific details on the quality, breadth, or responsiveness of these services, it is not possible to definitively distinguish between the two.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature Eko Foundation Analysis Software with Transformers (EFAST) Zio XT ECG Monitoring System
Name Eko Foundation Analysis Software with Transformers (EFAST) Zio XT ECG Monitoring System
Company Eko Health iRhythm Technologies
Description Advanced, FDA-cleared AI model that assists clinicians in identifying structural murmurs associated with heart disease and detecting atrial fibrillation, providing real-time, actionable cardiac insights during routine exams. Wearable, single-lead ECG biosensor for up to 14 days of continuous cardiac monitoring, utilizing FDA-cleared AI and expert review for accurate arrhythmia detection and diagnosis.
Key Features AI-powered structural murmur detection (93% sensitivity, 91% specificity); AI-powered atrial fibrillation (AFib) detection (95% sensitivity, 94% specificity); Real-time AI analysis during auscultation; Enhanced audio with noise cancellation and amplification; Waveform visualization and guided exams; Seamless integration with Eko digital stethoscopes (e.g., CORE 500); Cloud-based recording and secure storage of exams; EMR integration for streamlined documentation Wearable single-lead ECG biosensor (Zio biosensor); Continuous ambulatory cardiac monitoring for up to 14 days; Water-resistant design for normal daily activities, including showering; No external leads or wires for enhanced patient comfort and reduced artifacts; Proprietary, FDA-cleared deep-learned AI algorithm for ECG data analysis; Cloud-based software platform (ZEUS) for data storage, analysis, and reporting; Patient-activated button for symptomatic event logging; High patient compliance (up to 99%) and satisfaction
Specialties Cardiology, Family Medicine, Internal Medicine Cardiology, Emergency Medicine, Internal Medicine

Videos

Demos, reviews, and walkthroughs featuring Eko Foundation Analysis Software with Transformers (EFAST) and Zio XT ECG Monitoring System.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

EFAST by Eko Health is an advanced AI model that assists clinicians in identifying structural murmurs associated with heart disease and detecting atrial fibrillation (AFib) in real-time during routine exams. The Zio XT ECG Monitoring System by iRhythm Technologies, on the other hand, offers continuous cardiac monitoring for up to 14 days, utilizing AI and expert review for accurate arrhythmia detection and diagnosis.
EFAST analyzes acoustic data from auscultation, enhanced with noise cancellation and amplification, to detect structural murmurs and AFib. In contrast, Zio XT collects continuous single-lead ECG data via its wearable biosensor for comprehensive arrhythmia detection.
EFAST's AI-powered structural murmur detection has a reported 93% sensitivity and 91% specificity. Its AI-powered atrial fibrillation (AFib) detection achieves 95% sensitivity and 94% specificity.
EFAST offers EMR integration for streamlined documentation of cardiac exam findings. The Zio XT system utilizes a cloud-based software platform (ZEUS) for data storage, analysis, and reporting, but direct EMR integration is not explicitly detailed in the provided information for Zio XT.

Backers

Who funded each tool's parent company.

Eko Foundation Analysis Software with Transformers (EFAST)

AI Tool Finder
AI-powered search. Results may not be comprehensive.